344 related articles for article (PubMed ID: 7520771)
1. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
2. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.
Verfaillie CM; Catanzarro PM; Li WN
J Exp Med; 1994 Feb; 179(2):643-9. PubMed ID: 8294873
[TBL] [Abstract][Full Text] [Related]
3. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
Miller JS; McCullar V; Verfaillie CM
Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
[TBL] [Abstract][Full Text] [Related]
5. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
Verfaillie CM
Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
7. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.
Verfaillie C; Blakolmer K; McGlave P
J Exp Med; 1990 Aug; 172(2):509-2. PubMed ID: 2373991
[TBL] [Abstract][Full Text] [Related]
8. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
[TBL] [Abstract][Full Text] [Related]
9. Diffusible factors from the murine cell line M2-10B4 support human in vitro hematopoiesis.
Burroughs J; Gupta P; Blazar BR; Verfaillie CM
Exp Hematol; 1994 Oct; 22(11):1095-101. PubMed ID: 7523163
[TBL] [Abstract][Full Text] [Related]
10. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
Miller JS; Verfaillie C; McGlave P
Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
12. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
[TBL] [Abstract][Full Text] [Related]
13. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
[TBL] [Abstract][Full Text] [Related]
14. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
Roy V; Miller JS; Verfaillie CM
Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
[TBL] [Abstract][Full Text] [Related]
16. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells.
Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R
Blood; 1993 Aug; 82(3):784-91. PubMed ID: 7687893
[TBL] [Abstract][Full Text] [Related]
17. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential.
Muench MO; Cupp J; Polakoff J; Roncarolo MG
Blood; 1994 Jun; 83(11):3170-81. PubMed ID: 7514903
[TBL] [Abstract][Full Text] [Related]
19. The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors.
Waller EK; Olweus J; Lund-Johansen F; Huang S; Nguyen M; Guo GR; Terstappen L
Blood; 1995 May; 85(9):2422-35. PubMed ID: 7537114
[TBL] [Abstract][Full Text] [Related]
20. Phenotype and progeny of primitive adherent human hematopoietic progenitors.
Gordon MY; Lewis JL; Grand FH; Marley SB; Goldman JM
Leukemia; 1996 Aug; 10(8):1347-53. PubMed ID: 8709641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]